|
|
|
Volumn 27, Issue 2 SUPPL. 3, 2000, Pages 3-10
|
|
Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
DOCETAXEL;
GEMCITABINE;
IFOSFAMIDE;
NAVELBINE;
ANTINEOPLASTIC ACTIVITY;
ASTHENIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG TOLERABILITY;
HUMAN;
INFECTION;
LUNG NON SMALL CELL CANCER;
NEUTROPENIA;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
LUNG NEOPLASMS;
NEUTROPENIA;
PACLITAXEL;
TAXOIDS;
TREATMENT OUTCOME;
|
|
EID: 0034020173
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (31)
|
|
References (53)
|
